New York State Common Retirement Fund »

Enliven Therapeutics shares owned by New York State Common Retirement Fund

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by New York State Common Retirement Fund from 13F filings

Historical chart of New York State Common Retirement Fund investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by New York State Common Retirement Fund consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by New York State Common Retirement Fund

Quarter filed Position value Share count Share price at filing
2024-09-30 $703k 28k 25.55
2024-06-30 $541k 23k 23.35
2024-03-31 $165k 9.4k 17.60
2023-12-31 $130k 9.4k 13.83
2023-09-30 $129k 9.5k 13.65
2023-06-30 $188k 9.2k 20.43

More positions owned by New York State Common Retirement Fund

Apple Common Stock (AAPL)
Microsoft Corporation Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Inc - Class A Common Stock (GOOGL)
Alphabet Inc - Class C Common Stock (GOOG)
Berkshire Hathaway Inc-cl Common Stock (BRK.B)
Eli Lilly & Company Common Stock (LLY)
Broadcom Common Stock (AVGO)
Tesla Common Stock (TSLA)
Jp Morgan Chase & Company Common Stock (JPM)
Unitedhealth Group Common Stock (UNH)
Exxon Mobil Corporation Common Stock (XOM)
Visa Inc - Class A Common Stock (V)

View all positions for New York State Common Retirement Fund

Top funds holding Enliven Therapeutics

OrbiMed Advisors
Commodore Capital
VR Adviser
Fairmount Funds Management
BlackRock
BlackRock
Vanguard Group
5AM Venture Management
Citadel Advisors
RA Capital Management
Pictet Asset Management Holding SA
Woodline Partners
Soleus Capital Management
Geode Capital Management
Henderson Group

View all funds holding Enliven Therapeutics